IGC Pharma
IGC
#10740
Rank
ยฃ15.54 M
Marketcap
ยฃ0.13
Share price
-4.61%
Change (1 day)
-48.40%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

EPS for IGC Pharma (IGC)

EPS in 2026 (TTM): -ยฃ0.06719

According to IGC Pharma's latest financial reports the company's current EPS (TTM) is -ยฃ0.06813. In 2025 the company made an earnings per share (EPS) of -ยฃ0.06813 an increase over its 2024 EPS that were of -ยฃ0.17.

EPS history for IGC Pharma from 2006 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.06719-1.39%
2025-ยฃ0.06813-59.09%
2024-ยฃ0.17-0%
2023-ยฃ0.17-26.67%
2022-ยฃ0.2342.86%
2021-ยฃ0.1610.53%
2020-ยฃ0.1446.15%
2019-ยฃ0.09841116.67%
2018-ยฃ0.04542-14.29%
2017-ยฃ0.05299-58.82%
2016-ยฃ0.13-45.16%
2015-ยฃ0.23-16.22%
2014-ยฃ0.2815.63%
2013-ยฃ0.24-87.97%
2012-ยฃ2.01-80.15%
2011-ยฃ10.14219.05%
2010-ยฃ3.18740%
2009-ยฃ0.38-91.8%
2008-ยฃ4.62-654.55%
2007ยฃ0.83-178.57%
2006-ยฃ1.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sterling Infrastructure
STRL
ยฃ13.69-20,188.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
ยฃ3.10-4,644.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-ยฃ4.59 6,633.33%๐Ÿ‡บ๐Ÿ‡ธ USA